MRC1 and inflammatory bowel disease: It is worth noting that infliximab, a monoclonal antibody of anti-TNF-α, has been successfully used in the treatment of human IBD, and the regulatory macrophages CD68+CD206+ were induced in patients with IBD responsive to treatment (Vos et al., 2012; Danese et al., 2015).